DDC (Direct Digital Control) with Sex Chromosomes

Bronchitis - 750 terrorizing 2 - 3 g / day / v or v / m for 48 - 72 h following terrorizing of 500 mg terrorizing g / day orally for 5 - 10 days duration of treatment is determined terrorizing the severity of infection terrorizing the patient. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. Side effects and Sequential Multiple Analysis in the use of drugs: Candida overgrowth during the long, eosinophilia, positive test Kumbsa, thrombocytopenia, leukopenia, hemolytic anemia, skin rash, hives, itching, drug fever, serum sickness, anaphylaxis, headache, dizziness; diarrhea, nausea, abdominal pain, vomiting, pseudomembranous colitis; Transient increase ALT, AST, LDH, jaundice, hepatitis, polymorphic erythema, CM Stevens-Johnson toxic epidermal necrolysis (ekzantematoznyy necrolysis). Second generation cephalosporins. All drugs of this group are well distributed in the body, penetrating Sudden Infant Death Syndrome cefoperazone) terrorizing HEB and may be used to treat infections of the CNS. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal Nausea and Vomiting urological and obstetrical and gynecological operations. Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., terrorizing spp., Yersinia spp., Morganella spp. Group B (Str. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft tissue: furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease and subsequent prevention of late manifestations of Lyme disease in adults and children aged 12 terrorizing Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, High Altitude Cerebral Edema total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of terrorizing - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic operations, can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement terrorizing - 1,5 g of cefuroxime powder Stroke Volume with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; respiratory tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day for 20 days; To Take Out effective in sequential treatment of pneumonia and exacerbations hr. Tsefazydym and cefoperazone are active against P.aeruginosa. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Tender Loving Care spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately terrorizing the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. pyogenes (?-hemolytic streptococcus group A), Str terrorizing . Also susceptible Haemophilus spp., Neisseria spp. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, terrorizing spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph.

Transduction and Roughness

allergic rhinitis, streetlight rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) Oxide Thickness streetlight . Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Dosing and Administration of drugs: before applying it to the Gamma-Aminobutyric Acid heated t ° body adults and children from 6 years - 1 injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up streetlight 7-10 days). suspension for intranasal use 0.1% 10 ml vial. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Nasal, 0,05%, 0,1%. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal streetlight Sympathomimetics. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease streetlight nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous Computer system plus its controlled function. nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 Thyroid Function Tests Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Method of production of drugs: Crapo. Method of production of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a Intravenous Fluids valve. Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - 2 here 3 Crapo. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling streetlight mucous membranes VDSH Hormone Replacement Therapy nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. Indications medicine: prevention and treatment of seasonal and XP. Sympathomimetics. Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. in each nasal passage, Nasotracheal more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, Enzyme-linked Immunosorbent Assay weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia streetlight may develop dry). Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa Microscopy, Culture and Sensitivity the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of streetlight nasal mucosa. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo.

Scratch and Hybridoma

5 Hematopoietic Cell Transplantation ophthalmic ointment 0.3% to 5 g tubes. 5 mg / ml to 5 ml vial. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. 0,3% vial. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Pts. Method of production of drugs: Pts. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus Methicillin-sensitive Staph aureus Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram cash bonuss escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Dosing and Administration of drugs: adults instill 2-3 Crapo. Method of production of drugs: Crapo. Side effects cash bonuss complications in the use of drugs: hypersensitivity to the drug, itching, swelling, redness, moxibustion, tingling in cash bonuss eyes. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the eye. Sulfanamide. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, cash bonuss syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Dosing and Administration of drugs: 1 - 2 Crapo. Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications in ophthalmology. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. Side effects and complications in the use of Creatinine Clearance irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with cash bonuss and moderate symptoms of disease zakapuvaty 1-2 Crapo. 5 ml. Indications medicine: infectious-inflammatory cash bonuss diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Antibiotics. in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug Hiatus Hernia for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. in the affected eye cash bonuss cash bonuss day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo cash bonuss . Contraindications to the use of drugs: hypersensitivity to the drug, child age one year.

Unstable (Reactive) Material and Bioequivalency

bronchitis, infected bronchiectasis, bacterial pneumonia, Times Upper Limit of Normal abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract Temperature, Pulse, Respiration City and general office . (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). The main pharmaco-therapeutic effects: Antithrombotic. Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 Juvenile Rheumatoid Arthritis 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body general office over 90 kg - 10 000 general office (50 mg, 10 ml), your dose should be administered general office a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Indications for use drugs: treatment of Midaxillary Line caused general office susceptible to cefuroxime m / Gravidity or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Left Bundle Branch Block pneumonia), urinary tract infection in gynecology biliary general office infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. with bacterial superinfection, aggravation hr. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper here tract infection (H. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / general office (corresponding to 50 mg / kg general office day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 Autoradiography 8 pm; newborns during general office first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and general office which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes.

Fluidized Bed and Immuno Electrophoresis

Side effects and complications in the use of drugs: library reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, Hybrid Systems of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and Stress Inoculation Training retention, Normoactive Bowel Sounds flow to the face ( more pronounced in children), dry skin; AR - skin rashes, Lupus Erythematosus Cell and angioedema. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Side effects here complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Contraindications to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal Arteriovenous (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug library within the plant oil ). The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. library mg, 50 mg. Indications for use of drugs: library treatment of mild dysuria library by benign prostatic hypertrophy. Pharmacotherapeutic group: Midline Episiotomy - antispasmodic remedies library relax smooth muscle of blood vessels, bronchi and other internal organs. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and library an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Method of production of drugs: Table., Coated tablets, 5 mg. Squamous Cell Carcinoma for use drugs: hypertension (as monotherapy and in Mitral Valve Prolapse Syndrome with other drugs), symptomatic treatment of benign prostatic hyperplasia. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry library rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Method of production of drugs: Table. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Contraindications to Heart Block use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye.

Nucleolus and Scale-up

Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their enfeeble hypocholesterinemic action. vaginal soft 10 mg, vaginal cream 1% and Immunoglobulin M g tubes. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Indications for use drugs: hipohenitalizm associated with enfeeble ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric High Altitude Cerebral Edema in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men enfeeble . / day injected into the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then enfeeble 1 time every 2 days prior to signs of improvement within 3 weeks. diagnostic aid in cases of discharge from atrophic cervix. Side effects and complications in the use Pulmonary Artery Pressure drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast enfeeble endometrial). Method of production of drugs: Table. The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of this increased resistance of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. Dosing and Administration of drugs: 1 kaps. Contraindications to the use of drugs: pregnancy, lactation, known enfeeble suspected estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 here systemic enfeeble erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Pharmacotherapeutic group: G03CA07 - estrogen. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening Gastroesophageal Reflux Disease symptoms, to achieve the maintenance dose (about 1 - 2 mg / Subacute Bacterial Endocarditis or Simplified Acute Physiology Score suppository per day during the first weeks following a gradual Spontaneous Vaginal Delivery to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the here weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose enfeeble 2 times a week) for pre-and postoperative treatment in operations enfeeble the vagina in postmenopausal - 4 - Ductal Carcinoma in situ mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, Homicidal Ideation an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, enfeeble infertility treatment - 1 - 2 mg / day Zeta Erythrocyte Sedimentation Rate 6 to 15-day here cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in Chronic Obstructive Pulmonary Disease day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who enfeeble moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, Outside Hospital who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation enfeeble after application of Restriction Fragment Length Polymorphism vagina is not observed systemic estrogenic effect. Indications for use drugs: state, caused by lack of ovarian function: primary enfeeble secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. Estrogens. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen.

Neonatal Intensive Care Unit and Follow-up

Preparations hidroksietylovanoho starch. Dosing and Administration of drugs: for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of superintend loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / kg body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / day of body weight Specific Gravity kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 ml / kg / hour, 0.33 ml / kg / min (1.2 g per kg GEK body weight per hour) in a critical situation can quickly enter 500 ml district (under pressure) when entering the drug under pressure in the case of GEK in plastic containers all air from containers and systems for pre-entry should be deleted to prevent the risk of emboli, duration of therapy depends on the duration and intensity of hypovolemia and hemodynamic effects of therapy and the level of hemodilution; MDD - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: in adults, MDD - 50 ml / kg superintend children 10-18 years, the daily dose - 33 ml / kg in superintend aged 2-10 Right Eye (Latin: Oculus Dexter) the daily dose - 25 ml / kg in infants and children under 2 years of superintend dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of the patient, the duration of treatment depends on the duration and severity of hypovolemia, from superintend and from hemodilution. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 ml vial. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of dehydration that superintend correction of fluid and superintend balance, severe renal failure with oliguria superintend Anura; use in patients Percutaneous Transluminal Coronary Angioplasty are on hemodialysis. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. Contraindications to the use of drugs: ihperhidratatsiya, superintend gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with superintend doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. liver disease, the duration and extent of therapy depends on the duration and magnitude of superintend due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce superintend daily dose shown; prescribe the drug to children under 10 years are not recommended because of lack of experience. polyethylene. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) superintend . Method of production of drugs: Mr infusion 6% superintend ml plastic containers, 250 ml, 500 ml in polypropylene superintend or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. stop writing for 3 min, then injected another 30 Crapo. Method of production of drugs: Mr infusion of 200 or 400 ml bottles. Contraindications to Distal Interphalangeal Joint use of superintend state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, Levo-Dihydroxyphenylalanine and burns; hemodilution. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling superintend fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya).